Diagnostic Testing and Long-Term Monitoring

Because Andersen-Tawil Syndrome (ATS) is a “multi-system” condition, doctors must use several different tools to build a complete picture of how it affects your heart and muscles. A diagnosis is often based on the clinical phenotype—the physical symptoms and signs you show—even if a genetic cause cannot be found ^[1].

How ATS is Diagnosed

A diagnosis of ATS is typically supported if you meet a characteristic combination of clinical findings (such as muscle weakness, heart rhythm issues, or specific physical traits), or if you have one of these features plus a family member with a confirmed diagnosis ^[2].

While finding a pathogenic or likely pathogenic variant in the KCNJ2 or KCNJ5 gene provides strong molecular confirmation, a significant portion of people with a clear ATS clinical picture do not have an identified genetic mutation ^[3][4]. Therefore, a “negative” genetic test does not mean you don’t have ATS; it simply means your specific genetic “typo” hasn’t been discovered yet ^[3]. Note that a “Variant of Uncertain Significance” (VUS) does not establish the diagnosis on its own.

Cardiac Monitoring: More Than a Snapshot

The heart rhythm changes in ATS are often intermittent and can be “silent,” meaning you don’t feel them ^[5]. Because of this, a standard resting ECG—which only records the heart for a few seconds—is often insufficient for diagnosis or risk monitoring ^[6].

• Ambulatory Monitoring: This is superior to a baseline ECG because it records your heart while you go about your normal day ^[5]. A 24- to 48-hour Holter monitor is common, though your specialist may recommend a longer patch monitor depending on your age and symptoms. It is essential for detecting premature ventricular contractions (PVCs) and more complex rhythms like bidirectional ventricular tachycardia, which might not happen during a brief office visit ^[1][7].
• Characteristic ECG Findings: Specialists look for very specific patterns on your ECG that differ from other heart conditions.
  • Prominent U Waves: A “U wave” is a small extra hump after the main heartbeat. In ATS, these are often broad or very large ^[8][9].
  • Prolonged QU Interval: While doctors usually measure the QTc (the time the heart takes to reset), in ATS, the QU interval (which includes that extra U wave) is a more accurate marker of the syndrome’s electrical effect ^[1][8].

Neuromuscular Testing: The Long-Exercise Test

To investigate the periodic paralysis part of ATS, doctors may use a long-exercise test (also called the McManis protocol) ^[7].

During this test, you perform a sustained maximal voluntary contraction (often of the forearm). Then, repeated nerve stimulations measure the compound muscle action potential (CMAP)—the muscle’s electrical response. In many people with ATS, the muscle response will gradually drop as the muscle becomes “inexcitable” ^[7][10]. However, a normal result on this test does not rule out ATS, as some patients only show this drop during a real-life attack ^[5][2].

Ongoing Monitoring and Heart Health

Because the heart in ATS can experience frequent “extra beats” (PVCs), the heart muscle can sometimes become overworked over many years. This can lead to arrhythmia-induced cardiomyopathy, where the heart becomes slightly enlarged or weakened ^[11][12].

• Echocardiograms: Doctors use these ultrasound images of the heart to check its shape and pumping strength (the ejection fraction) ^[5].
• Reversibility: The good news is that if the heart muscle shows signs of weakening due to frequent extra beats, the condition is often reversible once the arrhythmias are better controlled with medication ^[13][11].

Regular follow-ups with both a neuromuscular specialist and a cardiac electrophysiologist (a heart rhythm specialist) are the standard for staying ahead of symptoms ^[5].